Bearbmagovva

Personalized Medicine in Oncology

Nowhere is the explosion in comprehensive genomic testing more evident than in oncology. Multiple consensus guidelines now recommend molecular testing as the standard of care for most metastatic tumors. To aid in the advancement of this rapidly changing field, we intend this Special Issue of JPM to...

Olles dieđut

Furkejuvvon:
Materiálatiipa: Online
Giella:eaŋgalasgiella
Almmustuhtton: MDPI - Multidisciplinary Digital Publishing Institute 2022
Fáttát:
patient-derived tumor xenograft (PDX)
anti-cancer drug development
immunodeficient mice
precision medicine
molecular profiling
immunohistochemistry
next-generation sequencing
targeted therapy
molecular oncology
biomarkers
molecular imaging
non-small cell lung cancer
proliferation
cancer stem cells
circulating tumour cells
personalised treatment
renal cell carcinoma
clear cell
VEGF
immunotherapy
PD-L1
immune checkpoint inhibitors
immune checkpoint blockade
tyrosine-kinase inhibitors
integrin-linked kinase (ILK)
ovarian cancer
sgRNA
gene expression
microarray
xenograft
MTB
cancer
oncology practice
community setting
CGP
pancreatic cancer
FOLFIRINOX
chemotherapy
gender
cholangiocarcinoma
biliary tract cancer
prognosis
neutrophils
BRCA1
BRCA2
PALB2
homologous recombination repair
colorectal cancer
heme oxygenase-1
endothelin-1
endothelin con-verting enzyme-1
bosentan
precision oncology
tumor-agnostic indications
solid tumors
tumor markers
FDA-approved therapeutics
n/a
thema EDItEUR::M Medicine and Nursing
Liŋkkat:ONIX_20220224_9783036528205_71
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid: Personalized Medicine in Oncology

Geahča maid